Cargando…
Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
BACKGROUND: The inflammatory tumor microenvironment, and more specifically the tumor‐associated macrophages, plays an essential role in the development and progression of prostate cancer towards metastatic bone disease. Tumors are often characterized by a leaky vasculature, which ‐ combined with the...
Autores principales: | Kroon, Jan, Buijs, Jeroen T., van der Horst, Geertje, Cheung, Henry, van der Mark, Maaike, van Bloois, Louis, Rizzo, Larissa Y., Lammers, Twan, Pelger, Rob C., Storm, Gert, van der Pluijm, Gabri, Metselaar, Josbert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006873/ https://www.ncbi.nlm.nih.gov/pubmed/25663076 http://dx.doi.org/10.1002/pros.22963 |
Ejemplares similares
-
The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis
por: van den Hoogen, Christel, et al.
Publicado: (2011) -
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer
por: Kroon, Jan, et al.
Publicado: (2016) -
Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth
por: Kroon, Jan, et al.
Publicado: (2013) -
An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer
por: Vrouwe, Josephina P. M., et al.
Publicado: (2021) -
Targeting of Alpha-V Integrins Reduces Malignancy of Bladder Carcinoma
por: van der Horst, Geertje, et al.
Publicado: (2014)